Patil Rajkumar V.
Chief Scientific Officer
PurchaseAlert
- Shares
- 3,363
- Price
- $1.49
- Value
- $5,011
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•28 filings
OKYO
OKYO Pharma Ltd
No net buying or selling imbalance over the last 3 months
No net buyers or sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found 1 CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
$0.00
0 buyers · 0 sellers
12-month purchases
$136,006
6 distinct insiders
12-month sales
$0.00
0 distinct insiders
Highlighted alerts
7
0 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
1 executive purchases found
Get OKYO insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
OKYO overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
19
Raw transactions
Everything returned by the filing
7
Voluntary view
P/S trades after deterministic checks
12
Administrative noise
Stored, never alerted
0
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- A
- Shares
- 3,363
- Price
- $1.49
- Footnotes
- —
No filing footnote was attached to this row.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Dempsey Robert John
CHIEF EXECUTIVE OFFICER
PurchaseAlert
- Shares
- 15,000
- Price
- $1.54
- Value
- $23,085
BRANCACCIO JOHN P
Director
PurchaseAlert
- Shares
- 5,000
- Price
- $1.48
- Value
- $7,385
JACOB GARY S
CHIEF DEVELOPMENT OFFICER
PurchaseAlert
- Shares
- 3,500
- Price
- $1.40
- Value
- $4,900
Mantelli Flavio
CHIEF MEDICAL OFFICER
PurchaseAlert
- Shares
- 20,000
- Price
- $1.40
- Value
- $28,000
CERRONE GABRIELE M
Director
PurchaseAlert
- Shares
- 22,500
- Price
- $1.45
- Value
- $32,625
CERRONE GABRIELE M
Director
PurchaseAlert
- Shares
- 25,000
- Price
- $1.40
- Value
- $35,000
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Jul 27, 2026 | Patil Rajkumar V. Chief Scientific Officer | Purchase | 3,363 | $1.49 | $5,011 | |
| Jul 22, 2026 | Dempsey Robert John CHIEF EXECUTIVE OFFICER | Purchase | 15,000 | $1.54 | $23,085 | |
| Jul 21, 2026 | BRANCACCIO JOHN P Director | Purchase | 5,000 | $1.48 | $7,385 | |
| Jul 21, 2026 | JACOB GARY S CHIEF DEVELOPMENT OFFICER | Purchase | 3,500 | $1.40 | $4,900 | |
| Jul 21, 2026 | Mantelli Flavio CHIEF MEDICAL OFFICER | Purchase | 20,000 | $1.40 | $28,000 | |
| Jul 21, 2026 | CERRONE GABRIELE M Director | Purchase | 22,500 | $1.45 | $32,625 | |
| Jul 20, 2026 | CERRONE GABRIELE M Director | Purchase | 25,000 | $1.40 | $35,000 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.